We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
This paper discusses the planning of the different steps associated to projects featuring high risk/high return characteristics, which require FDA approval. We present a model that connects early decision making, such as level and intensity of pre-testing or investment on facilities, among others, with the FDA approval process and the final(More)
  • 1